GPT and metabolic dysfunction-associated steatotic liver disease: The levels of ALT (Table 1) were significantly increased (p < p = 0.026) in the NAFLD group (25.0 ± 6.4 mg/dL) compared to the CG group (6.8 ± 0.9 mg/dL).